Marinus Pharmaceuticals, Inc. (MRNS) Covered Calls
There are no covered calls available for Marinus Pharmaceuticals, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Marinus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in three different dose forms: intravenous (IV), capsule, and liquid. The multiple dose forms are intense to maximize the therapeutic range of ganaxolone for adults and pediatric patients. Ganaxolone acts as an anti-seizure, anti-anxiety, and anti-depressive actions; and acts on synaptic and extra synaptic GABAA receptors. The company is also developing ganaxolone for pediatric refractory epilepsy; postpartum depression; and acute epilepsy, which are in Phase II clinical study. In addition, it is developing ganaxolone IV formulation to treat status epilepticus. Marinus Pharmaceuticals, Inc. has a collaboration agreement with NovaMedica, LLC; and license agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc. The company was founded in 2003 and is based in Radnor, Pennsylvania
| Top 10 Open Interest For Mar 21 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | KWEB covered calls | 1. | LUNR covered calls | |
| 2. | FXI covered calls | 7. | INTC covered calls | 2. | HIMS covered calls | |
| 3. | SPY covered calls | 8. | SLV covered calls | 3. | RGTI covered calls | |
| 4. | EEM covered calls | 9. | QQQ covered calls | 4. | SOUN covered calls | |
| 5. | IWM covered calls | 10. | HYG covered calls | 5. | WOLF covered calls | |
Want more examples? MRNA Covered Calls | MRSN Covered Calls
